CISN - How Cancer is Studied - Glossary of Epidemiology Terms
| You Are Here: Home > Cancer Research > How Cancer is Studied > Epidemiology > Glossary of Epidemiology Terms |
Glossary of Epidemiology TermsAgent: A causative factor, such as a biological or chemical agent that must be present (or absent) in the environment for disease occurrence in a susceptible host. Aggregate data: Data combined from several measurements or sets of measurements. Analytic epidemiologic studies: Studies that examine groups of individuals in order to make comparisons and associations and to determine causal relationships; also known as cohort and case-control studies. Bias: Any process or factor at any stage of a study from, its design to its execution to the application of information from the study, that produces results or conclusions that skew the results. Case-control study: An analytic epidemiologic study design that assembles study groups after a disease has occurred; also called a retrospective study. Cohort study: An analytic epidemiologic study type that assembles study groups before disease occurrence to observe and compare the rates of a health outcome over time; also called a prospective study. Confounding factor: The distortion of the effect of one risk factor by the presence of another. Correlation study: A descriptive epidemiologic study design used to compare aggregate populations for potential exposures of disease. Cross- sectional survey: A descriptive epidemiologic study design that uses a representative sample of the population to collect information on current health status, personal characteristics, and potential risk factors or exposures at one point in time. Descriptive epidemiologic studies: Epidemiologic study designs that contribute to the description of a disease or condition by examining the essential features of person, place, and time. Environment: Internal and external factors that constitute the context for agent-host interactions; one's surroundings of any type. Epidemic: A number of cases of an infectious agent or disease (outbreak) clearly in excess of the normally expected frequency of that disease in that population. Exposure: The process by which an agent comes into contact with a person or animal in such a way that the person or animal may develop disease. Incidence: The number of new cases of a disease diagnosed each year. |
| Section Index | |
| What We Know About Cancer | |
| ● | How Cancer is Studied |
| Drug Development | |
| New Treatments | |
| Research Advocacy | |
Intervention study: Epidemiologic study design that is experimental in nature and used to test a hypothesis about a cause-and-effect relationship. Morbidity rate: A disease rate, specifically prevalence and incidence rates of diseases in a population in a specified time period. Mortality rate: The number of deaths from all causes divided by the total population at a particular time and place. Observational studies: Nonexperimental studies that describe, compare, and explain disease occurrence. Prevalence: The total number of cases of the disease in the population at a given time divided by the number of individuals in the population. Prevention:
Prospective study: An epidemiologic study design that assembles study groups before disease occurrence. Random error: Is just that, random. It can occur during data collection (then called sampling error), coding, transfer, or analysis. Relative risk: An epidemiologic measure of association that indicates the likelihood that an exposed group will develop a disease or condition relative to those not exposed. Retrospective study: An epidemiologic study design that assembles study groups after disease occurrence. Risk: The probability that an event, outcome, disease, or condition will develop in a specified time period. Selection bias: The sampled group is biased in that it does not accurately represent the population it is intended to represent. Sensitivity: The probability that an individual who has the disease of interest will have a positive screening test result. A test with high sensitivity has few false negatives, so you do not miss people with the disease. Specificity: The probability that an individual who does not have the disease of interest will have a negative screening test result. A test with high specificity has few false positives so you do not identify people with no disease are rarely missed or told they don't have the disease.
Systematic error: An error that is constant in a series of repetitions of the same experiment or observation. For example a scale could be set inaccurately. Surveillance: The systematic collection and evaluation of all aspects of disease occurrence and spread, resulting in information that may be useful in the control of the disease. Therapeutic trials: An epidemiologic intervention study design used to compare measures or interventions aimed at therapeutic benefits. Validity: The validity of a study is dependent on the degree of systematic error. Validity is usually separated into two components:
You have reached the end of this section. If you wish to test your knowledge of "How Cancer is Studied"For more information about our e-Training courses, please read the e-Quiz Introduction. |
| |